Matthew R. Silver
Lawyers
Filters
Marsh McLennan $1.6 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Marsh McLennan $600 million senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
VF €1 billion senior notes offering, including €500 million in green bonds
We advised VF on the investment-grade debt offering
CureVac $250 million follow-on offering
We advised CureVac on the equity offering
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
CSX $2 billion senior notes offering
We advised CSX on the investment-grade debt offering